Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;63(11):1149-1163.
doi: 10.1111/myc.13145. Epub 2020 Sep 23.

Characteristics, outcome and risk factors for mortality of paediatric patients with ICU-acquired candidemia in India: A multicentre prospective study

Arunaloke Chakrabarti  1 , Prashant Sood  1 , Shivaprakash M Rudramurthy  1 , Sharon Chen  2 , Joseph Jillwin  1 , Ranganathan Iyer  3 , Ajanta Sharma  4 , Belgode Narasimha Harish  5 , Indranil Roy  6 , Anupma J Kindo  7 , Deepinder Chhina  8 , Jayanthi Savio  9 , Deepak Mendiratta  10 , Malini R Capoor  11 , Shukla Das  12 , Anita Arora  13 , Jagdish Chander  14 , Immaculata Xess  15 , Appalaraju Boppe  16 , Ujjwayini Ray  17 , Ratna Rao  18 , Vandana Kalwaje Eshwara  19 , Sangeeta Joshi  20 , Atul Patel  21 , Raman Sardana  22 , Anjali Shetty  23 , Umabala Pamidimukkala  24 ; SIHAM Candidemia Network
Affiliations

Characteristics, outcome and risk factors for mortality of paediatric patients with ICU-acquired candidemia in India: A multicentre prospective study

Arunaloke Chakrabarti et al. Mycoses. 2020 Nov.

Abstract

Background: The epidemiology, clinical profile and outcome of paediatric candidemia vary considerably by age, healthcare settings and prevalent Candida species. Despite these differences, few comprehensive studies are undertaken. This nationwide study addresses this knowledge gap.

Methods: 487 children who contracted ICU-acquired candidemia at 23 Indian tertiary care centres were assessed for 398 variables spanning demography, clinical characteristics, microbiology, treatment and outcome.

Results: Both neonates (5.0 days; range = 3.0-9.5) and non-neonatal children (7.0 days; range = 3.0-13.0) developed candidemia early after ICU admission. Majority of neonates were premature (63.7%) with low birthweight (57.1%). Perinatal asphyxia (7.3%), pneumonia (8.2%), congenital heart disease (8.4%) and invasive procedures were common comorbidities, and antibiotic use (94.1%) was widespread. C tropicalis (24.7%) and C albicans (20.7%) dominated both age groups. Antifungal treatment (66.5%) and removal of central catheters (44.8%) lagged behind. Overall resistance was low; however, emergence of resistant C krusei and C auris needs attention. The 30-day crude mortality was 27.8% (neonates) and 29.4% (non-neonates). Logistic regression identified admission to public sector ICUs (OR = 5.64), mechanical ventilation (OR = 2.82), corticosteroid therapy (OR = 8.89) and antifungal therapy (OR = 0.22) as independent predictors of 30-day crude mortality in neonates. Similarly, admission to public sector ICUs (OR = 3.62), mechanical ventilation (OR = 3.13), exposure to carbapenems (OR = 2.18) and azole antifungal therapy (OR = 0.48) were independent predictors for non-neonates.

Conclusions: Our findings reveal a distinct epidemiology, including early infection with a different spectrum of Candida species, calling for appropriate intervention strategies to reduce candidemia morbidity and mortality. Independent factors identified in our regression models can help tackle these challenges.

Keywords: Candida albicans; Candida auris; Candida tropicalis; antibiotic prophylaxis; candidemia; intensive care; neonates; paediatric.

PubMed Disclaimer

References

REFERENCES

    1. Filioti J, Spiroglou K, Roilides E. Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med. 2007;33:1272-1283.
    1. Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34:1-14.
    1. Blyth CC, Chen SC, Slavin MA, et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 2009;123:1360-1368.
    1. Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20(Suppl 6):5-10.
    1. Zaoutis T. Candidemia in children. Curr Med Res Opin. 2010;26:1761-1768.

LinkOut - more resources